London · Delayed Price · Currency is GBP · Price in GBX Convatec Group Earnings Call Transcripts
Fiscal Year 2026
-
The Accelerate strategy builds on a successful turnaround, targeting 6%-8% organic revenue growth, mid-20s operating margin, and double-digit EPS growth. Growth is driven by robust innovation, new product launches across all categories, capacity expansion, and disciplined capital allocation.
Fiscal Year 2025
-
Delivered strong organic revenue and margin growth in 2025, with double-digit EPS and robust cash flow. 2026 guidance targets 5%-7% organic growth and at least 23% margin, despite reimbursement headwinds. From 2027, expects 6%-8% annual growth and mid-twenties margin.
-
Broad-based organic revenue growth and strong product launches underpin confidence in meeting 2025 and medium-term targets. Despite regulatory headwinds for InnovaMatrix, margin expansion and double-digit EPS growth are expected, supported by innovation and increased CapEx.
-
Strong H1 2025 results with 6.8% organic revenue growth, 130 bps margin expansion, and 19% EPS growth. Guidance reaffirmed despite potential 1%-2% revenue headwinds from CMS proposals, with continued investment in innovation and manufacturing capacity.
-
Organic revenue growth reached 6.7% (excluding InnovaMatrix), with broad-based gains across all categories and strong innovation driving new product launches. Guidance for 2025 is tightened, with revenue growth expected between 5.5%-7% and at least $75 million in InnovaMatrix sales.
Fiscal Year 2024
-
Achieved record 2024 results with 7.7% organic revenue growth, margin expansion, and double-digit EPS and free cash flow growth. 2025 guidance targets 5%-7% organic growth (ex-InnovaMatrix), further margin gains, and continued strong cash generation despite regulatory headwinds.
-
Organic sales growth reached 7.7% year-to-date, prompting upgraded 2024 sales and margin guidance. All business segments contributed, with strong product innovation and robust emerging market growth. Margin expansion is supported by operational improvements and lower inflation.
-
Strong H1 2024 results with 6.6% organic revenue growth, margin expansion, and robust cash flow. Guidance for 2024 and medium term reaffirmed, with new product launches and operational efficiencies supporting double-digit EPS and cash flow growth.